| Augmentation of endothelial function following exercise training is associated with increased L-arginine transport in human heart failure. | |
| | |
MedLine Citation:
|
PMID: 16117723 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We have reported previously a decrease in the clearance of the NO (nitric oxide) precursor L-arginine in the forearm circulation of CHF (congestive heart failure) patients, suggesting a potential rate-limiting mechanism contributing to the common finding of endothelial dysfunction in CHF. Given data that show exercise training augments endothelial function in CHF, the aim of the present study was to investigate whether these improvements were due to an increase in L-arginine transport. Measures of L-arginine transport, endothelial function and exercise capacity were repeated before and after 8 weeks of "usual living" or exercise training in 21 CHF patients [NYHA (New York Heart Association) class II/III]. Exercise capacity (6-min walk test) increased following exercise training (496+/-21 to 561+/-17 m; P=0.005), whereas the control group demonstrated no change [488+/-18 to 484+/-21 m; P=ns (not significant)]. Basal FBF (forearm blood flow) remained stable following exercise training (2.68+/-0.55 to 2.46+/-0.32 ml.min(-1).100 ml(-1) of tissue) and "usual living" (2.16+/-0.37 to 2.91+/-0.55 min(-1).100 ml(-1) of tissue). FBF responses to ACh (acetylcholine) increased following exercise by 49.6+/-17.7% (area under curve; P=0.01) demonstrating augmented endothelial function. FBF responses to SNP (sodium nitroprusside) were also improved following exercise training (30.8+/-8.2%; P=0.02). There was no change in vascular function in the "usual living" group. The clearance of L-arginine was significantly increased following involvement in the exercise programme (69.4+/-7.8 to 101.0+/-9.5 ml/min; P=0.04), whereas there was no change in the "usual living" group (78.4+/-17.5 to 81.0+/-14.9 ml/min; P=ns). In conclusion, the augmentation in endothelial function observed following exercise may be due, in part, to an increase in the transport of L-arginine in CHF patients. |
| | |
Authors:
|
Melinda M Parnell; Diane P Holst; David M Kaye |
Related Documents
:
|
15470653 - Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted ... 17306703 - Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic ch... 1907603 - Inspiratory muscle relaxation rate after voluntary maximal isocapnic ventilation in hum... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical science (London, England : 1979) Volume: 109 ISSN: 0143-5221 ISO Abbreviation: Clin. Sci. Publication Date: 2005 Dec |
Date Detail:
|
Created Date: 2005-11-18 Completed Date: 2006-01-13 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7905731 Medline TA: Clin Sci (Lond) Country: England |
Other Details:
|
Languages: eng Pagination: 523-30 Citation Subset: IM |
Affiliation:
|
Wynn Department of Metabolic Cardiology, Baker Medical Research Institute, St Kilda Road Central, Melbourne, Victoria 8008, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetylcholine
/
diagnostic use Analysis of Variance Arginine / analogs & derivatives, blood, metabolism* Biological Transport Case-Control Studies Endothelium, Vascular / metabolism* Exercise Tolerance Forearm / blood supply Heart Failure / metabolism*, therapy Humans Male Metabolic Clearance Rate Middle Aged Myocardium / metabolism* Nitroprusside / diagnostic use Physical Education and Training* Regional Blood Flow / drug effects Vasodilator Agents / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Vasodilator Agents; 0/dimethylarginine; 15078-28-1/Nitroprusside; 51-84-3/Acetylcholine; 74-79-3/Arginine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of chromium picolinate and biotin in the management of type 2 diabetes: an economic analysis.
Next Document: Poly(ADP-ribose) glycohydrolase is a component of the FMRP-associated messenger ribonucleoparticles.